Filing Details
- Accession Number:
- 0001177648-18-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-02 16:22:29
- Reporting Period:
- 2018-10-01
- Accepted Time:
- 2018-10-02 16:22:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1177648 | Enanta Pharmaceuticals Inc | ENTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1599020 | Tim Ocain | C/O Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-01 | 15,000 | $19.98 | 21,127 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2018-10-01 | 10,000 | $32.27 | 31,127 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-10-01 | 3,500 | $82.04 | 27,627 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-01 | 6,219 | $83.47 | 21,408 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-01 | 14,677 | $84.02 | 6,731 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-01 | 604 | $85.30 | 6,127 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-10-01 | 15,000 | $0.00 | 15,000 | $19.98 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-10-01 | 10,000 | $0.00 | 10,000 | $32.27 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-10-29 | No | 4 | M | Direct | |
60,000 | 2024-01-30 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $81.84 to $82.21, inclusive.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $82.77 to $83.76, inclusive.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.77 to $84.73, inclusive.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.915 to $85.67, inclusive.
- 100% of the shares subject to this option are fully vested and exercisable.